I’m a medical doctor at the National Center for Tumor Diseases (NCT) Heidelberg. I received my M.D. with distinction from Heidelberg University. Simultaneously, I obtained a M.Sc. & B.Sc. in Management & Technology (major in biochemistry and finance & accounting) with high distinction from TU Munich and MIT. Further, I received a M.Sc. & Ph.D. in Economics with magna cum laude from the University of Wuppertal and the LSE.
My previous work experience in consulting, venture capital, private equity, and finance focused on the biotech and healthcare industries. I (co-)authored +50 publications in leading medical journals (e.g. BMJ, JCO, JNCI, JNCCN) and conferences (e.g. ESMO, ASCO, ISPOR, ESC). My research focuses on drug development, clinical trials, and healthcare policy.
